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Letters to the EditorThe reporting of animal welfare details in liver research: A review
of studies describing bile duct ligation in mice (2011–2013)To the Editor:
Studies involving animals play a key role in basic liver research
and are most commonly carried out in laboratory mice. For exam-
ple, bile duct ligation (BDL) is frequently carried out to model a
range of hepatic pathologies including ﬁbrosis and cholestasis
[1]. When animals are used experimentally it is widely accepted
that procedures should be reﬁned to alleviate pain and distress
[2]. Promoting laboratory animal welfare is not only of
ethical value but of considerable scientiﬁc importance to
minimize variability and improve validity of research involving
animals [2–4].
Given the clear importance of reﬁning experimental proce-
dures, we conducted a literature review to assess the reporting
of details related to mouse welfare in studies that involved BDL
in mice. Although the BDL procedure is widely used in rats and
has been well characterized for many years [5], it is increasingly
carried out in mice because of the number of genetically altered
mouse strains now available [1]. The search was performed in
July 2014, using the search engine SCOPUS and search terms
‘‘mouse OR mice’’ and ‘‘bile duct ligation OR BDL’’ within key-
word, title and abstract to identify relevant studies, published
in English between 2011 and 2013. A paper was eligible for inclu-
sion if it described mice undergoing experimental BDL and was
available in electronic format from Newcastle University. Confer-
ence papers, letters and reviews were excluded. Papers (including
supplementary data) were then carefully screened to identify
details relating to animal welfare.
119 papers met our inclusion criteria (34 from 2011, 39 from
2012 and 46 from 2013); journals in which they were published
are summarized in Table 1. Papers most commonly described
mechanisms of cholestatic liver injury (66.4%) and therapeutic
or toxic substances (17.6%). Transgenic mice were studied in
55.5% of the papers. The BDL procedure was carried out in North
America (39%), Europe (27%) or Asia (24%). 10% of studies
involved multiple institutions and the place where the animal
work was carried out was not speciﬁed. 94% of papers made a
statement related to ethical guidelines on the humane use of ani-
mals, with 86.6% of these studies referring to local ethical
approval. The ‘‘Guide for the Care and Use of Laboratory Animals’’
[6] was the most frequently cited guideline relating to animal
care (22.7% of papers).
Surgical and anaesthetic details were described in 57% of the
papers, whereas 43% of the papers only referred to methods
described in previous studies. Of the papers citing previously
published methodologies, 26.7% referred to studies carried out
in rats, which is problematic given the species differences (e.g.
the gallbladder is present in mice and absent in rats). When
methods were not described, we recorded anaesthetic and anal-
gesic details from papers whose methodologies had been cited.
Overall, only 3.4% of studies describing BDL in mice speciﬁed
administration of a systemic analgesic agent (non-steroidal
anti-inﬂammatory or opioid agent); administration of
buprenorphine (n = 3) and fentanyl (n = 1) was reported in 2
papers from North America and in 2 from Europe. Administration
of a systemic analgesic agent to mice undergoing BDL is consid-
erably lower than has been previously reported for mice and rats,
undergoing a range of surgical procedures (typically 20%) [4,7].
This is surprising given that BDL is a painful procedure in rodents,
although pain can be alleviated through systemic analgesic
administration [8]. Although it is possible that systemic analge-
sics were administered in these studies, but not reported (e.g.
investigators may view analgesic administration as implicit in
their statement relating to ethical guidelines), earlier work sug-
gests that under-reporting of analgesic administration is rela-
tively low [4]. Furthermore, the reporting of details in animal
research should be comprehensive to allow experiments to be
repeated [9]. Space restraints for reporting methodological
details in some journals, particularly those with a high impact
factor, may also be perceived as an obstacle for some authors
however, an increasing number of journals allow authors to
include supplementary data. Alternatively, papers which report
animal welfare information in detail could be cited with any
modiﬁcations to the published protocol clearly described. Anal-
gesics may have been withheld if investigators had concerns
about potential effects of the analgesics, however, uncontrolled
post-surgical pain is a source of considerable experimental vari-
ability [4] and not a feature of cholestatic liver disease in most
human patients.
Thirty percent of studies had no information concerning the
anaesthetic protocol used. When the anaesthetic regimen was
speciﬁed, the most common agents were: ketamine/xylazine
(30%), isoﬂurane (29%), pentobarbital (18%) and ether (12%). Only
27.7% of studies described the administration of an anaesthetic
agents with analgesic properties (ketamine, alfentanyl, tribromo-
ethanol, tiletamine). Three of the anaesthetic regimens used give
rise to potential animal welfare concerns: irritancy on induction
(ether), narrow safety margin (pentobarbital) and unpredictable
adverse effects (tribromoethanol) [3,4].
As bile duct ligation induces progressive disease and is associ-
ated with considerable morbidity and mortality [1], reﬁnement of
the BDL procedure should not just be limited to the peri-opera-
tive period and appropriate monitoring/supportive care is essen-
tial throughout the study [3,10]. Although 6.7% of studies
speciﬁed saline injections and 5% described clinical monitoring,
relatively few studies reported the provision of supportive care.
A warm environment and soaked diet is generally beneﬁcial to
sick animals [3], but only 16% of studies reported the room
temperature, which was not increased after surgery (18–21 C
[2.5%], 21–23 C [13.5%]) and provision of a soaked diet was
not reported. Experimental and humane end points are also
particularly important in progressive disease studies where
pain and distress are more likely to occur as disease progresses
[11]. Although a small number of studies (less than 3%) continued
for more than 6 weeks following BDL, when mice would
have developed advanced disease, the majority (95%) speciﬁed
clear experimental end points with 95% of end points at
4 weeks or earlier. Humane end points were referred to in one
paper.250 Journal of Hepatology 2015 vol. 62 j 238–251
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Given the clear importance of the humane treatment of
laboratory animals with respect to both animal welfare and the
translation of in vivo studies to human patients with liver disease,
we would encourage investigators, carrying out research involv-
ing animals, to implement reﬁnements and to report the mea-
sures taken to minimise pain and distress according to the
ARRIVE guidelines [9]. Speciﬁc recommendations for animals that
have undergone surgery include provision and reporting of an
appropriate systemic analgesic, or the rationale if analgesics
had been withheld. Finally, both the anaesthetic regimen and
reﬁnement details relating to the post-operative period (e.g.
monitoring, nursing care and humane end points) should be
speciﬁed.
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Table 1. Journals included in review.
Journal name Number of papers 
included in review
Hepatology 22
Journal of Hepatology 14
Gastroenterology 9
American Journal of Physiology-  
Gastrointestinal and Liver Physiology
8
PLOS ONE 7
Liver International 6
The American Journal of Pathology 4
Laboratory Investigation 4
Biochemical and Biophysical Research 
Communications
4
Biochimica et Biophysica Acta 3
Free Radical Biology and Medicine 2
European Journal of Pharmacology 2
Journal of Biological Chemistry 2
Experimental and Toxicologic Pathology 2
Journals with one paper included in the 
review*
30
⁄American Journal of Physiology, Behavioural Brain Research, BMC Gastroenter-
ology, Clinical and Experimental Medicine, European Radiology, Food and
Chemical Toxicology, Gut, Gut Microbes, Journal of Clinical Investigation, Journal
of Gastrointestinal Surgery, Journal of Hepato-Biliary-Pancreatic Sciences, Journal
of Immunology, Journal of Toxicological Sciences, Journal of Leukocyte Biology,
Journal of Nuclear Medicine, Journal of Pharmacology, Journal of Surgical
Research, Molecular Nutrition and Food Research, Molecular Biology Reports,
Molecular and Cellular Biology, Pathophysiology, Peptides, Pharmaceutical Biol-
ogy, PLoS Genetics, Proceedings of the National Academy of Sciences of the United
States of America Plus, Psychopharmacology, Surgery, Toxicological Sciences,
Toxicology, Toxicology and Applied Pharmacology.
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